Nifty Pharma Today Rises 0.54% in Early Trade: Key Stocks

Updated: 6 Aug 2026 • 10:01 am

Posted by:

Nifty Pharma Today Rises 0.54% in Early Trade: Key Stocks

6 August 2026, Opening Bell:Nifty Pharma was the strongest sector index in the early session, rising 144.10 points, or 0.54%, to 26,707.65 at 10:00:00 AM IST. The advance came with 14 of 20 tracked pharma stocks in positive territory, while Gland Pharma, Lupin and Cipla led the gainers. Here is what nifty pharma today is showing in early trade.

Quick sector takeaways

Nifty Pharma gained 0.54% to 26,707.65, compared with its previous close of 26,563.55.
The index traded between 26,583.20 and 26,736.55 during the early session, with the latest level close to the day’s high.
Breadth was positive: 14 stocks advanced, six declined and none were unchanged among 20 display-safe constituents.
Gland Pharma, Lupin and Cipla were notable gainers, while JB Chemicals & Pharmaceuticals was the largest individual decliner. Watch whether the positive breadth holds through the session.

Nifty Pharma today: early-session strength

Nifty Pharma today opened at 26,593.85 and moved higher in the opening phase, reaching 26,736.55 before easing modestly to 26,707.65 at the stated update time. Even after that pullback from the intraday high, the index remained 144.10 points above the previous close of 26,563.55.

The early move places the pharma gauge at the top of the configured sector-index gainers for this update. The index was also above its opening level by 113.80 points. Its position near the upper end of the morning range is an observation of price action, while the positive count across constituent stocks provides a broader view of the early advance.

Price snapshot

Metric	Level	Early-session reading
Last traded price	26,707.65	Up 144.10 points or 0.54%
Previous close	26,563.55	Reference level for the day’s gain
Day open	26,593.85	Above the previous close
Day high	26,736.55	29.20 points above the latest level
Day low	26,583.20	124.45 points below the latest level

The index’s intraday range so far is 153.35 points, measured from the day low to the day high. The latest reading sits 124.45 points above the low and 29.20 points below the high. This keeps the opening-bell snapshot constructive on price position, while the remaining session will determine how the range develops.

Sector ranking

Nifty Pharma is the top gaining sector index among the configured indices in this update, with its 0.54% gain ahead of Nifty Financial Services at 0.12%, Nifty Bank and Nifty Mid Select at 0.10% each, and Nifty FMCG at 0.02%. Several other configured indices were lower at the same time, including Nifty IT, Nifty Metal and Nifty Auto.

This ranking is based on the percentage move in the index itself, rather than a single constituent’s move. For readers tracking sector rotation at the opening bell, pharma’s lead reflects the strongest percentage performance within this configured comparison set at 10:00:00 AM IST.

Constituent breadth

The breadth profile was positive, with 14 advancers against six decliners and no unchanged stocks across 20 display-safe Nifty Pharma constituents. That is an advance-decline ratio of 2.33, meaning there were more than two advancing stocks for every declining stock in the early reading.

Positive breadth matters because the index rise was accompanied by gains across a majority of the tracked basket rather than being limited to one or two names. At the same time, six stocks were lower, showing that participation was favourable but not uniform. The difference in individual stock moves remains important alongside the headline index gain.

Heavyweights versus broader participation

The supplied heavyweight list showed a mixed but largely positive early picture. Sun Pharmaceutical Industries rose 0.88% to Rs 1,957, while Divi's Laboratories added 0.49% to Rs 8,429.50. Torrent Pharmaceuticals was up 0.27% and Cipla gained 1.38%, whereas Dr. Reddy's Laboratories was down 0.73%.

The same set of names also appears in the supplied active-stock context. Sun Pharma, Divi's Laboratories, Torrent Pharmaceuticals and Cipla were positive, while Dr. Reddy's was negative. This mix supports the view that the sector’s advance had participation among several prominent names, even as not every heavyweight moved in the same direction.

Key Nifty Pharma stocks

Stock	Move	Why it matters
Gland Pharma	Up 1.87% to Rs 2,592.80	Largest percentage gainer in the supplied list.
Lupin	Up 1.48% to Rs 2,423.40	Among the leading positive movers in early trade.
Cipla	Up 1.38% to Rs 1,478.90	Positive move among the supplied heavyweight names.
Granules India	Up 1.18% to Rs 855.05	Extended the positive participation beyond the largest names.
JB Chemicals & Pharmaceuticals	Down 3.87% to Rs 2,408.90	Largest percentage decliner in the supplied list.

Biggest positive movers

Gland Pharma led the gainers with a 1.87% rise to Rs 2,592.80. Lupin followed with a 1.48% gain to Rs 2,423.40, while Cipla advanced 1.38% to Rs 1,478.90. Granules India gained 1.18% and Biocon rose 1.16%.

Gland Pharma traded between Rs 2,557 and Rs 2,601.30, with its latest level below the day high. Lupin’s latest price of Rs 2,423.40 was also below its intraday high of Rs 2,427.70. Cipla traded at Rs 1,478.90 against a high of Rs 1,480.90, an early-session positioning detail worth monitoring rather than an explanation for the move.

Biggest negative movers

JB Chemicals & Pharmaceuticals fell 3.87% to Rs 2,408.90, making it the largest decliner in the supplied sector list. Aurobindo Pharma was down 0.83% to Rs 1,600, Dr. Reddy's Laboratories declined 0.73% to Rs 1,167.40, and Alkem Laboratories slipped 0.47% to Rs 5,669.50. Zydus Lifesciences was lower by 0.29%.

These declines did not overturn the sector’s positive breadth at the update time, but they show the dispersion within pharma stocks. JB Chemicals & Pharmaceuticals traded as low as Rs 2,380 after opening at Rs 2,506, while Aurobindo Pharma’s day range extended from Rs 1,584.20 to Rs 1,634.40.

Stocks to watch next session

Gland Pharma, Lupin, Cipla, Sun Pharmaceutical Industries, Divi's Laboratories and JB Chemicals & Pharmaceuticals stand out for monitoring after this early update. The first five were either among the strongest gainers or represented positive heavyweight participation, while JB Chemicals & Pharmaceuticals was the sharpest decliner.

Investors can track whether these names retain their individual direction and whether their combined movement continues to support the broader index. Their opening-session ranges and closing position within those ranges may offer a useful follow-through read in the next session.

The constructive case

The constructive evidence is visible in the index gain, the positive breadth and the mix of advancing stocks. Nifty Pharma was up 0.54%, led the configured sector-index rankings, and held close to its intraday high at the update time. Fourteen of 20 tracked stocks were higher.

Leadership was also not restricted to a single name. Gland Pharma, Lupin, Cipla, Granules India and Biocon were all up by more than 1%, while Sun Pharma, Divi's Laboratories and Torrent Pharmaceuticals also posted gains. This combination of broad participation and positive heavyweight moves underpins the early constructive reading.

The cautious case

The sector advance coexisted with six declining stocks, including a 3.87% fall in JB Chemicals & Pharmaceuticals. Aurobindo Pharma, Dr. Reddy's Laboratories, Alkem Laboratories, Zydus Lifesciences and Ipca Laboratories were also lower. The index was below its day high by 29.20 points at the snapshot time.

Accordingly, the opening strength should be read as an early-session condition rather than a completed-day outcome. The balance between the 14 advancers and six decliners, and the index’s location within its daily range, are the immediate figures to follow.

Univest Insights

The key opening-bell feature in nifty pharma today is the alignment of index performance and constituent breadth. A 0.54% rise with 14 advances out of 20 stocks presents a more balanced picture than an index move driven by only a small number of shares.

Price action also places the index near the top of its opening range: 26,707.65 versus the day high of 26,736.55. That leaves the index modestly below the morning peak after rising from an open of 26,593.85 and a low of 26,583.20.

The internal stock picture remains selective. Gland Pharma, Lupin and Cipla provided the strongest percentage gains among the listed leaders, while the decline in JB Chemicals & Pharmaceuticals and weakness in several other stocks highlight the need to assess both breadth and dispersion.

For a wider market context, visit Univest Market View. For traders and investors, the key signal to watch is…

Published on 6 August 2026 at 10:00 AM IST

Frequently asked questions

What is Nifty Pharma today?

Nifty Pharma was at 26,707.65 at 10:00:00 AM IST on 6 August 2026, up 144.10 points or 0.54% from the previous close of 26,563.55.

Why is Nifty Pharma the top gaining sector index?

Its 0.54% rise was the highest percentage gain among the configured sector indices in this opening-bell update.

What were Nifty Pharma’s day high and day low?

The index recorded a day high of 26,736.55 and a day low of 26,583.20 in the early session.

How was Nifty Pharma market breadth?

Fourteen of 20 display-safe constituent stocks advanced, six declined and none were unchanged, producing an advance-decline ratio of 2.33.

Which stocks gained the most in Nifty Pharma?

Gland Pharma rose 1.87%, Lupin gained 1.48% and Cipla advanced 1.38% in the supplied early-session data.

Which stock was the biggest Nifty Pharma decliner?

JB Chemicals & Pharmaceuticals was the largest decliner, down 3.87% to Rs 2,408.90.

Disclaimer

Investments in securities markets are subject to market risks. Read all related documents carefully before investing. This sector-index update is for informational and educational purposes only and is not personalized investment advice or a recommendation to buy, sell, or hold any security.